Ciara Curtin writes science features for GenomeWeb and is the editor of the Daily Scan and Careers blogs.
Though the effect of reference bias was inconsistent, the authors of a new study said it highlights the need for tools or approaches to minimize it.
Respondents to GenomeWeb's salary survey reported variations in their salaries that varied by sector.
A study presented at the National Society of Genetic Counselors annual meeting last week analyzed how counseling sessions affected patients on five measures.
Genetic counselors, laboratories, and patients themselves have roles to play in reclassifying gene variants, including variants of uncertain significance.
At the National Society of Genetic Counselors annual meeting, a number of clinicians said they conduct their own investigations of variants in clinical lab reports.
At ASM Microbe, the University of Wisconsin's Caitlin Pepperell described her work putting Mycobacterium tuberculosis genomics into a historical context.
Public health microbiologists are forging ahead with WGS, even as others caution that it may not yet be ready for such a role, said speakers at ASM Microbe 2018.
Metagenomics can help researchers and clinicians uncover sources of infectious disease and discern whether pathogens are resistant to antimicrobials.
The London School of Hygiene and Tropical Medicine's Sharon Peacock argued a sequencing-based pathogen surveillance approach could uncover outbreaks faster.
Genome-wide association study hits can uncover potential therapies for conditions like inflammatory bowel disease, a Biology of Genomes speaker said.
An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.
In Science this week: reduction in bee phylogenetic diversity, and more.
The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.
The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.